Friday, April 17, 2026

#FGEN

102 articles

FibroGen Soars 30% In 21 Days: Is It Time To Buy?

FibroGen Soars 30% In 21 Days: Is It Time To Buy?

ViaNews Editorial Team•Dec 9, 2023

LendingTree And Advaxis On The List Of Winners And Losers Of Thursday's US Session

LendingTree And Advaxis On The List Of Winners And Losers Of Thursday's US Session

ViaNews Editorial Team•Dec 7, 2023

FibroGen Soars 26% In 5 Sessions: Is It Time To Buy?

FibroGen Soars 26% In 5 Sessions: Is It Time To Buy?

ViaNews Editorial Team•Dec 6, 2023

FibroGen Stock Plummets 12.3% In One Day: Is It Time To Sell?

FibroGen Stock Plummets 12.3% In One Day: Is It Time To Sell?

ViaNews Editorial Team•Dec 6, 2023

FibroGen Stock Was Up By 13.12% Today

FibroGen Stock Was Up By 13.12% Today

ViaNews Editorial Team•Dec 2, 2023

Zhongchao And NASDAQ TEST STOCK On The List Of Winners And Losers Of Saturday's US Session

Zhongchao And NASDAQ TEST STOCK On The List Of Winners And Losers Of Saturday's US Session

ViaNews Editorial Team•Dec 2, 2023

FibroGen Soars 13%: Investors Bet On Promising Drug Trial Results

FibroGen Soars 13%: Investors Bet On Promising Drug Trial Results

ViaNews Editorial Team•Dec 2, 2023

FibroGen Stock Bullish Momentum With A 9.35% Rise Before The Weekend

FibroGen Stock Bullish Momentum With A 9.35% Rise Before The Weekend

ViaNews Editorial Team•Dec 1, 2023

ImmunoGen And Verb Technology Company On The List Of Winners And Losers Of Friday's US Session

ImmunoGen And Verb Technology Company On The List Of Winners And Losers Of Friday's US Session

ViaNews Editorial Team•Dec 1, 2023

FibroGen Stock 17.47% Up On Thursday

FibroGen Stock 17.47% Up On Thursday

ViaNews Editorial Team•Nov 30, 2023

PAVmed And PAVmed On The List Of Winners And Losers Of Thursday's US Session

PAVmed And PAVmed On The List Of Winners And Losers Of Thursday's US Session

ViaNews Editorial Team•Nov 30, 2023

FibroGen Soars 17% Ahead Of Market, Investors Rejoice

FibroGen Soars 17% Ahead Of Market, Investors Rejoice

ViaNews Editorial Team•Nov 30, 2023

FibroGen Stock Plummets 22% In 5 Sessions: Is It Time To Sell?

FibroGen Stock Plummets 22% In 5 Sessions: Is It Time To Sell?

ViaNews Editorial Team•Nov 28, 2023

Gap And Roadrunner Transportation Systems On The List Of Winners And Losers Of Saturday's US Session

Gap And Roadrunner Transportation Systems On The List Of Winners And Losers Of Saturday's US Session

ViaNews Editorial Team•Nov 18, 2023

FibroGen Stock Bullish Momentum With A 11.92% Jump On Wednesday

FibroGen Stock Bullish Momentum With A 11.92% Jump On Wednesday

ViaNews Editorial Team•Nov 15, 2023

Youngevity International And NASDAQ TEST STOCK On The List Of Winners And Losers Of Tuesday's US Session

Youngevity International And NASDAQ TEST STOCK On The List Of Winners And Losers Of Tuesday's US Session

ViaNews Editorial Team•Nov 14, 2023

FibroGen Shares Plunge Over 12%

FibroGen Shares Plunge Over 12%

ViaNews Editorial Team•Nov 11, 2023

FibroGen Already 6% Up, Almost Two Hours Before The Market Open

FibroGen Already 6% Up, Almost Two Hours Before The Market Open

ViaNews Editorial Team•Nov 6, 2023

FibroGen Stock Impressive Jump On Saturday, Outperforms Market

FibroGen Stock Impressive Jump On Saturday, Outperforms Market

ViaNews Editorial Team•Nov 4, 2023

Republic First Bancorp And Fortinet On The List Of Winners And Losers Of Saturday's US Session

Republic First Bancorp And Fortinet On The List Of Winners And Losers Of Saturday's US Session

ViaNews Editorial Team•Nov 4, 2023